These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8235693

  • 1. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group.
    Hiddemann W, Unterhalt M, Pott C, Wörmann B, Sandford D, Freund M, Engert A, Gassmann W, Holtkamp W, Seufert J.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):28-31. PubMed ID: 8235693
    [Abstract] [Full Text] [Related]

  • 2. Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas.
    Bocchia M, Bigazzi C, Marconcini S, Forconi F, Marotta G, Algeri R, Lauria F.
    Haematologica; 1999 Aug; 84(8):716-20. PubMed ID: 10457407
    [Abstract] [Full Text] [Related]

  • 3. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
    Bremer K.
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
    Casasnovas RO, Haioun C, Dumontet C, Gabarre J, Richard B, Lederlin P, Caillot D, Stamatoullas A, Morel P, Quesnel B, Blay JY, Bouabdallah K, Gisselbrecht C.
    Haematologica; 2000 May; 85(5):502-7. PubMed ID: 10800167
    [Abstract] [Full Text] [Related]

  • 5. Fludarabine in low-grade lymphoma.
    Pigaditou A, Rohatiner AZ, Whelan JS, Johnson PW, Ganjoo RK, Rossi A, Norton AJ, Amess J, Lim J, Lister TA.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):24-7. PubMed ID: 8235692
    [Abstract] [Full Text] [Related]

  • 6. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL, Levrero MG, Lauria F, Rondelli D, Zaja F, Russo D, Fanin R, De Rossi G, Mauro FR, Bendandi M, Gozzetti A, Dianzani F, Mandelli F, Tura S.
    Haematologica; 1994 Oct; 79(1):55-60. PubMed ID: 15378949
    [Abstract] [Full Text] [Related]

  • 7. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
    Czuczman MS, Koryzna A, Mohr A, Stewart C, Donohue K, Blumenson L, Bernstein ZP, McCarthy P, Alam A, Hernandez-Ilizaliturri F, Skipper M, Brown K, Chanan-Khan A, Klippenstein D, Loud P, Rock MK, Benyunes M, Grillo-Lopez A, Bernstein SH.
    J Clin Oncol; 2005 Feb 01; 23(4):694-704. PubMed ID: 15681517
    [Abstract] [Full Text] [Related]

  • 8. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr 01; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 9. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
    Shields DJ, Byrd JC, Abbondanzo SL, Lichy JH, Diehl LF, Aguilera NI.
    Mod Pathol; 1997 Nov 01; 10(11):1151-9. PubMed ID: 9388067
    [Abstract] [Full Text] [Related]

  • 10. Fludarabine in lymphoproliferative malignancies: a single-centre experience.
    Prabhash K, Vikram GS, Nair R, Sengar M, Gujral S, Bakshi A, Gupta S, Parikh PM.
    Natl Med J India; 2008 Nov 01; 21(4):171-4. PubMed ID: 19267037
    [Abstract] [Full Text] [Related]

  • 11. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
    Forstpointner R, Hänel A, Repp R, Hermann S, Metzner B, Pott C, Hartmann F, Rothmann F, Böck HP, Wandt H, Unterhalt M, Hiddemann W.
    Dtsch Med Wochenschr; 2002 Oct 25; 127(43):2253-8. PubMed ID: 12397539
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr 25; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 13. FLU-ID (fludarabine and idarubicin) regimen as salvage therapy in pretreated low-grade non-Hodgkin's lymphoma.
    Zinzani PL, Bendandi M, Gherlinzoni F, Merla E, Gozzetti A, Tura S.
    Haematologica; 1996 Apr 25; 81(2):168-71. PubMed ID: 8641650
    [Abstract] [Full Text] [Related]

  • 14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 25; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 15. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ, Taylor PR, Angus B, Wood K, Lennard AL, Lucraft H, Carey PJ, Stark A, Iqbal A, Haynes A, Russel N, Leonard RC, Culligan D, Conn J, Jackson GH.
    Eur J Haematol Suppl; 2001 Jul 25; 64():28-32. PubMed ID: 11486397
    [Abstract] [Full Text] [Related]

  • 16. Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Wiernik PH, Lossos IS, Tuscano JM, Justice G, Vose JM, Cole CE, Lam W, McBride K, Wride K, Pietronigro D, Takeshita K, Ervin-Haynes A, Zeldis JB, Habermann TM.
    J Clin Oncol; 2008 Oct 20; 26(30):4952-7. PubMed ID: 18606983
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of lymphoma patients with fludarabine-based regimens: a report of 29 cases].
    Huang HQ, Jiang WQ, Peng YL, Xia ZJ, Li YH, Li XB, Lin TY, Sun XF, Guan ZZ.
    Ai Zheng; 2004 Apr 20; 23(4):448-51. PubMed ID: 15087037
    [Abstract] [Full Text] [Related]

  • 18. [Treatment with fludarabine of lymphoid neoplasms with low grade malignity resistant to treatment or in relapse].
    Briones J, Montserrat E, Urbano-Ispizua A, Esteve J, Colomer D, López-Guillermo A, Bosch F, Hadjieu E, Rozman C.
    Med Clin (Barc); 1996 Jun 15; 107(3):86-9. PubMed ID: 8754493
    [Abstract] [Full Text] [Related]

  • 19. Idarubicin in low-grade non-Hodgkin's lymphomas.
    Zinzani PL.
    Haematologica; 1997 Jun 15; 82(5 Suppl):23-4. PubMed ID: 9402750
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A, Slavin S, Varadi G, Naparstek E, Samuel S, Or R.
    Bone Marrow Transplant; 2000 May 15; 25(10):1021-8. PubMed ID: 10828860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.